| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Cells, Circulating | 61 | 2025 | 950 | 9.420 |
Why?
|
| Microfluidic Analytical Techniques | 61 | 2025 | 788 | 8.680 |
Why?
|
| Cell Separation | 40 | 2024 | 1718 | 6.350 |
Why?
|
| Microfluidics | 37 | 2025 | 651 | 5.450 |
Why?
|
| Cryoprotective Agents | 28 | 2024 | 123 | 5.240 |
Why?
|
| Cryopreservation | 42 | 2024 | 728 | 4.860 |
Why?
|
| Trehalose | 33 | 2018 | 88 | 4.420 |
Why?
|
| Lab-On-A-Chip Devices | 10 | 2023 | 426 | 3.030 |
Why?
|
| Ice | 7 | 2022 | 102 | 2.650 |
Why?
|
| Desiccation | 21 | 2014 | 77 | 2.130 |
Why?
|
| Hepatocytes | 31 | 2024 | 1247 | 2.100 |
Why?
|
| Water | 12 | 2019 | 1417 | 1.660 |
Why?
|
| Vitrification | 5 | 2023 | 47 | 1.580 |
Why?
|
| Blood Preservation | 4 | 2023 | 168 | 1.350 |
Why?
|
| Leukapheresis | 3 | 2025 | 150 | 1.330 |
Why?
|
| Electroporation | 2 | 2024 | 238 | 1.290 |
Why?
|
| Pseudomonas syringae | 3 | 2018 | 33 | 1.240 |
Why?
|
| Oocytes | 14 | 2020 | 1169 | 1.220 |
Why?
|
| Freezing | 15 | 2024 | 310 | 1.210 |
Why?
|
| Polyvinyl Alcohol | 2 | 2018 | 74 | 1.160 |
Why?
|
| Leukocytes | 10 | 2017 | 2027 | 1.120 |
Why?
|
| Particle Size | 12 | 2018 | 1631 | 1.070 |
Why?
|
| Liver, Artificial | 10 | 2008 | 55 | 1.050 |
Why?
|
| Semen Preservation | 10 | 2016 | 35 | 1.010 |
Why?
|
| Spermatozoa | 14 | 2016 | 629 | 0.990 |
Why?
|
| Blood Cells | 2 | 2017 | 307 | 0.990 |
Why?
|
| Microchemistry | 5 | 2014 | 54 | 0.970 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2018 | 431 | 0.960 |
Why?
|
| Alginates | 3 | 2017 | 247 | 0.960 |
Why?
|
| Cell Movement | 12 | 2020 | 5194 | 0.930 |
Why?
|
| Organ Preservation | 7 | 2024 | 399 | 0.910 |
Why?
|
| Glycerol | 8 | 2021 | 274 | 0.910 |
Why?
|
| Polyethylene Glycols | 10 | 2024 | 1188 | 0.890 |
Why?
|
| Erythrocytes | 9 | 2023 | 2395 | 0.890 |
Why?
|
| Equipment Design | 25 | 2020 | 3481 | 0.880 |
Why?
|
| Cell Membrane Permeability | 4 | 2017 | 562 | 0.860 |
Why?
|
| High-Throughput Screening Assays | 3 | 2020 | 938 | 0.850 |
Why?
|
| Cell Survival | 27 | 2024 | 5747 | 0.800 |
Why?
|
| Capillaries | 2 | 2016 | 755 | 0.790 |
Why?
|
| Cell Line, Tumor | 45 | 2022 | 17075 | 0.780 |
Why?
|
| Cell Size | 5 | 2017 | 625 | 0.770 |
Why?
|
| Biomedical Engineering | 4 | 2018 | 284 | 0.770 |
Why?
|
| Nanotechnology | 5 | 2013 | 703 | 0.730 |
Why?
|
| Neutrophils | 12 | 2017 | 3776 | 0.720 |
Why?
|
| RNA, Neoplasm | 7 | 2020 | 745 | 0.720 |
Why?
|
| Cell Membrane | 6 | 2024 | 3634 | 0.670 |
Why?
|
| Models, Chemical | 4 | 2009 | 608 | 0.660 |
Why?
|
| Oscillometry | 1 | 2020 | 151 | 0.660 |
Why?
|
| Cell Culture Techniques | 13 | 2014 | 1652 | 0.650 |
Why?
|
| Blood Platelets | 3 | 2020 | 2464 | 0.640 |
Why?
|
| Flow Cytometry | 11 | 2017 | 5881 | 0.640 |
Why?
|
| Single-Cell Analysis | 11 | 2025 | 2535 | 0.630 |
Why?
|
| Cumulus Cells | 1 | 2018 | 22 | 0.630 |
Why?
|
| Dehydration | 5 | 2011 | 215 | 0.610 |
Why?
|
| Microarray Analysis | 4 | 2009 | 752 | 0.600 |
Why?
|
| Cell Aggregation | 3 | 2016 | 238 | 0.600 |
Why?
|
| Dimethylpolysiloxanes | 6 | 2023 | 142 | 0.600 |
Why?
|
| Quartz | 2 | 2008 | 23 | 0.590 |
Why?
|
| Animals | 124 | 2024 | 168764 | 0.590 |
Why?
|
| Temperature | 17 | 2015 | 2226 | 0.590 |
Why?
|
| Cold Temperature | 7 | 2024 | 794 | 0.570 |
Why?
|
| Oocyte Retrieval | 1 | 2018 | 163 | 0.570 |
Why?
|
| Organ Preservation Solutions | 4 | 2024 | 105 | 0.560 |
Why?
|
| Rats | 35 | 2024 | 23707 | 0.550 |
Why?
|
| Tissue Engineering | 16 | 2011 | 1855 | 0.550 |
Why?
|
| Blood Specimen Collection | 1 | 2018 | 238 | 0.540 |
Why?
|
| Deuterium Oxide | 1 | 2016 | 34 | 0.540 |
Why?
|
| Surface Properties | 13 | 2017 | 1151 | 0.540 |
Why?
|
| Membranes, Artificial | 3 | 2008 | 362 | 0.530 |
Why?
|
| Oils | 1 | 2016 | 54 | 0.520 |
Why?
|
| Ficoll | 1 | 2016 | 39 | 0.520 |
Why?
|
| Cell Adhesion | 13 | 2020 | 3089 | 0.510 |
Why?
|
| Preservation, Biological | 5 | 2011 | 26 | 0.500 |
Why?
|
| Chemotactic Factors | 2 | 2009 | 195 | 0.500 |
Why?
|
| Exosomes | 2 | 2018 | 421 | 0.490 |
Why?
|
| Cells, Cultured | 22 | 2024 | 18973 | 0.490 |
Why?
|
| Electromagnetic Phenomena | 1 | 2016 | 160 | 0.480 |
Why?
|
| Liver | 11 | 2024 | 7562 | 0.480 |
Why?
|
| Artemia | 3 | 2012 | 6 | 0.480 |
Why?
|
| Immunoassay | 3 | 2020 | 741 | 0.470 |
Why?
|
| Burns | 9 | 2010 | 1903 | 0.470 |
Why?
|
| CHO Cells | 3 | 2011 | 1372 | 0.470 |
Why?
|
| Breast Neoplasms | 23 | 2023 | 21056 | 0.460 |
Why?
|
| Hydrodynamics | 2 | 2019 | 163 | 0.460 |
Why?
|
| Humans | 175 | 2025 | 765968 | 0.450 |
Why?
|
| Blood Component Removal | 2 | 2024 | 124 | 0.450 |
Why?
|
| Insect Proteins | 2 | 2014 | 253 | 0.450 |
Why?
|
| Cryptosporidium | 2 | 2024 | 43 | 0.440 |
Why?
|
| Coculture Techniques | 11 | 2023 | 1336 | 0.440 |
Why?
|
| Neoplasm Metastasis | 13 | 2022 | 4893 | 0.440 |
Why?
|
| Hydrogels | 8 | 2021 | 728 | 0.440 |
Why?
|
| CD4 Lymphocyte Count | 4 | 2009 | 2587 | 0.440 |
Why?
|
| Perfusion | 6 | 2022 | 1407 | 0.430 |
Why?
|
| Microspheres | 3 | 2014 | 773 | 0.420 |
Why?
|
| Proteins | 5 | 2024 | 5995 | 0.420 |
Why?
|
| Nanopores | 1 | 2013 | 45 | 0.410 |
Why?
|
| Magnetics | 3 | 2013 | 585 | 0.410 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2014 | 252 | 0.400 |
Why?
|
| Crystallization | 4 | 2018 | 521 | 0.400 |
Why?
|
| RNA | 9 | 2021 | 2717 | 0.400 |
Why?
|
| Fibroblasts | 8 | 2019 | 4159 | 0.400 |
Why?
|
| Staphylococcus aureus | 2 | 2018 | 1424 | 0.400 |
Why?
|
| 3-O-Methylglucose | 3 | 2016 | 37 | 0.400 |
Why?
|
| Models, Theoretical | 5 | 2018 | 3564 | 0.390 |
Why?
|
| Sperm Injections, Intracytoplasmic | 7 | 2018 | 156 | 0.390 |
Why?
|
| Receptors, Androgen | 6 | 2024 | 1088 | 0.390 |
Why?
|
| Glass | 3 | 2008 | 116 | 0.380 |
Why?
|
| Diptera | 1 | 2011 | 51 | 0.380 |
Why?
|
| Models, Biological | 10 | 2020 | 9443 | 0.370 |
Why?
|
| Stromal Cells | 4 | 2019 | 1329 | 0.370 |
Why?
|
| Rats, Inbred Lew | 12 | 2010 | 1167 | 0.370 |
Why?
|
| Biopolymers | 1 | 2012 | 181 | 0.370 |
Why?
|
| Micromanipulation | 2 | 2016 | 53 | 0.370 |
Why?
|
| Cell Tracking | 1 | 2012 | 139 | 0.360 |
Why?
|
| Chemotaxis, Leukocyte | 4 | 2010 | 657 | 0.350 |
Why?
|
| Neoplasms | 11 | 2025 | 22340 | 0.350 |
Why?
|
| Nanostructures | 3 | 2015 | 548 | 0.350 |
Why?
|
| Tissue Preservation | 3 | 2012 | 169 | 0.350 |
Why?
|
| Epithelial-Mesenchymal Transition | 7 | 2022 | 752 | 0.350 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2011 | 437 | 0.340 |
Why?
|
| Filtration | 2 | 2008 | 224 | 0.340 |
Why?
|
| Prostatic Neoplasms | 13 | 2025 | 11083 | 0.330 |
Why?
|
| Mice | 62 | 2023 | 81819 | 0.330 |
Why?
|
| Models, Cardiovascular | 1 | 2015 | 978 | 0.330 |
Why?
|
| Antigens, Neoplasm | 2 | 2018 | 2002 | 0.330 |
Why?
|
| Blood | 2 | 2019 | 597 | 0.330 |
Why?
|
| Biocompatible Materials | 6 | 2018 | 1682 | 0.320 |
Why?
|
| Lymphocytes | 4 | 2006 | 2599 | 0.320 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2009 | 13 | 0.320 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2009 | 111 | 0.320 |
Why?
|
| Porosity | 4 | 2012 | 347 | 0.320 |
Why?
|
| Point-of-Care Systems | 5 | 2022 | 1217 | 0.320 |
Why?
|
| Cells | 2 | 2014 | 162 | 0.320 |
Why?
|
| Mammals | 4 | 2024 | 1125 | 0.320 |
Why?
|
| Computer Simulation | 5 | 2018 | 6255 | 0.310 |
Why?
|
| Embryonic Stem Cells | 4 | 2008 | 1241 | 0.310 |
Why?
|
| Microchip Analytical Procedures | 2 | 2023 | 28 | 0.310 |
Why?
|
| Nanoparticles | 2 | 2011 | 1964 | 0.310 |
Why?
|
| Freeze Drying | 3 | 2018 | 97 | 0.310 |
Why?
|
| Permeability | 4 | 2013 | 726 | 0.300 |
Why?
|
| Antifreeze Proteins | 2 | 2018 | 12 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 12 | 2021 | 8611 | 0.300 |
Why?
|
| Sequence Analysis, RNA | 10 | 2020 | 2034 | 0.300 |
Why?
|
| Fractionation, Field Flow | 1 | 2007 | 3 | 0.300 |
Why?
|
| Entrepreneurship | 1 | 2008 | 23 | 0.290 |
Why?
|
| Gene Expression Profiling | 11 | 2017 | 9525 | 0.290 |
Why?
|
| Motion | 2 | 2008 | 781 | 0.290 |
Why?
|
| Flow Injection Analysis | 1 | 2007 | 21 | 0.290 |
Why?
|
| Embryo, Nonmammalian | 1 | 2011 | 907 | 0.280 |
Why?
|
| Tissue Array Analysis | 1 | 2009 | 545 | 0.280 |
Why?
|
| Insulin | 5 | 2024 | 6599 | 0.280 |
Why?
|
| Keratinocytes | 3 | 2006 | 863 | 0.270 |
Why?
|
| Sperm Motility | 4 | 2016 | 265 | 0.270 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2008 | 335 | 0.270 |
Why?
|
| Blastocyst | 7 | 2020 | 432 | 0.270 |
Why?
|
| Video Recording | 1 | 2012 | 969 | 0.270 |
Why?
|
| Time Factors | 27 | 2019 | 40065 | 0.270 |
Why?
|
| Nonlinear Dynamics | 1 | 2009 | 490 | 0.260 |
Why?
|
| Polymethacrylic Acids | 1 | 2006 | 31 | 0.260 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2010 | 3797 | 0.260 |
Why?
|
| Micropore Filters | 1 | 2005 | 23 | 0.260 |
Why?
|
| Cell Count | 7 | 2022 | 1823 | 0.250 |
Why?
|
| Biomedical Technology | 2 | 2007 | 210 | 0.250 |
Why?
|
| Specimen Handling | 4 | 2021 | 704 | 0.250 |
Why?
|
| Cell Line | 15 | 2017 | 15543 | 0.250 |
Why?
|
| Intracellular Membranes | 2 | 2005 | 386 | 0.240 |
Why?
|
| Antibodies, Immobilized | 2 | 2018 | 17 | 0.240 |
Why?
|
| Medicine | 1 | 2013 | 942 | 0.240 |
Why?
|
| Laser Scanning Cytometry | 1 | 2004 | 5 | 0.240 |
Why?
|
| Mitochondria, Liver | 1 | 2005 | 190 | 0.240 |
Why?
|
| Antibodies | 4 | 2016 | 2417 | 0.230 |
Why?
|
| Eukaryotic Cells | 1 | 2006 | 192 | 0.230 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2005 | 149 | 0.230 |
Why?
|
| Sucrose | 4 | 2016 | 155 | 0.230 |
Why?
|
| Epithelial Cells | 5 | 2018 | 3681 | 0.230 |
Why?
|
| Liver Failure | 2 | 2004 | 252 | 0.230 |
Why?
|
| HIV Seropositivity | 2 | 2007 | 961 | 0.230 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 2 | 2021 | 66 | 0.230 |
Why?
|
| Thrombosis | 1 | 2018 | 2949 | 0.230 |
Why?
|
| Fructose | 1 | 2006 | 286 | 0.230 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2011 | 747 | 0.230 |
Why?
|
| Kinetics | 8 | 2012 | 6274 | 0.220 |
Why?
|
| Cell Proliferation | 11 | 2021 | 10429 | 0.220 |
Why?
|
| Female | 72 | 2025 | 396112 | 0.220 |
Why?
|
| Carbohydrates | 2 | 2005 | 386 | 0.220 |
Why?
|
| 3T3 Cells | 7 | 2010 | 1081 | 0.220 |
Why?
|
| Shear Strength | 3 | 2014 | 160 | 0.220 |
Why?
|
| Stress, Mechanical | 4 | 2015 | 1668 | 0.220 |
Why?
|
| Cricetinae | 3 | 2011 | 2411 | 0.220 |
Why?
|
| Rheology | 3 | 2012 | 348 | 0.210 |
Why?
|
| Radium | 1 | 2024 | 70 | 0.210 |
Why?
|
| Cryptosporidium parvum | 1 | 2023 | 35 | 0.210 |
Why?
|
| Centrifugation | 2 | 2015 | 121 | 0.210 |
Why?
|
| Pancreatic Neoplasms | 5 | 2022 | 5444 | 0.210 |
Why?
|
| Interleukin-8 | 2 | 2005 | 700 | 0.210 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2024 | 412 | 0.210 |
Why?
|
| Muscular Atrophy | 1 | 2006 | 335 | 0.210 |
Why?
|
| Hemolysin Proteins | 1 | 2003 | 112 | 0.210 |
Why?
|
| Cryptosporidiosis | 1 | 2023 | 52 | 0.210 |
Why?
|
| Emulsions | 2 | 2016 | 150 | 0.210 |
Why?
|
| Male | 65 | 2025 | 363698 | 0.200 |
Why?
|
| Biological Assay | 2 | 2023 | 627 | 0.200 |
Why?
|
| Hindlimb | 2 | 2024 | 510 | 0.200 |
Why?
|
| Nitrogen | 5 | 2011 | 346 | 0.200 |
Why?
|
| Hemolysis | 1 | 2004 | 406 | 0.200 |
Why?
|
| Commerce | 1 | 2008 | 611 | 0.200 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2003 | 355 | 0.200 |
Why?
|
| Protein Array Analysis | 1 | 2004 | 399 | 0.200 |
Why?
|
| Heat-Shock Response | 3 | 2009 | 179 | 0.200 |
Why?
|
| Thermodynamics | 4 | 2009 | 580 | 0.200 |
Why?
|
| Dextrans | 1 | 2004 | 571 | 0.200 |
Why?
|
| Monocytes | 2 | 2009 | 2595 | 0.190 |
Why?
|
| Models, Animal | 4 | 2019 | 2120 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 6 | 2021 | 6113 | 0.190 |
Why?
|
| Culture Media | 5 | 2021 | 890 | 0.190 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2012 | 1663 | 0.190 |
Why?
|
| Equipment and Supplies | 1 | 2004 | 273 | 0.190 |
Why?
|
| Phase Transition | 4 | 2019 | 73 | 0.190 |
Why?
|
| Hypoglycemic Agents | 2 | 2006 | 3110 | 0.190 |
Why?
|
| Clinical Protocols | 1 | 2007 | 1441 | 0.190 |
Why?
|
| Research | 2 | 2008 | 1975 | 0.190 |
Why?
|
| Reproducibility of Results | 8 | 2020 | 20124 | 0.190 |
Why?
|
| Microscopy, Fluorescence | 6 | 2015 | 2627 | 0.190 |
Why?
|
| Osmosis | 5 | 2010 | 103 | 0.180 |
Why?
|
| Bioreactors | 5 | 2011 | 244 | 0.180 |
Why?
|
| Aneuploidy | 1 | 2025 | 578 | 0.180 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2011 | 4405 | 0.180 |
Why?
|
| Fetal Blood | 1 | 2007 | 1369 | 0.180 |
Why?
|
| Ion Channels | 1 | 2005 | 1045 | 0.180 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2020 | 58 | 0.180 |
Why?
|
| Silicon | 2 | 2013 | 141 | 0.170 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 4618 | 0.170 |
Why?
|
| Polymers | 6 | 2011 | 1621 | 0.170 |
Why?
|
| Hydrogen Bonding | 2 | 2018 | 293 | 0.170 |
Why?
|
| Polystyrenes | 2 | 2012 | 102 | 0.170 |
Why?
|
| HeLa Cells | 3 | 2024 | 3067 | 0.170 |
Why?
|
| Larva | 3 | 2023 | 511 | 0.170 |
Why?
|
| Zebrafish | 2 | 2023 | 3036 | 0.170 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 4528 | 0.170 |
Why?
|
| Hexuronic Acids | 2 | 2017 | 144 | 0.170 |
Why?
|
| Glucuronic Acid | 2 | 2017 | 148 | 0.170 |
Why?
|
| Mice, SCID | 6 | 2022 | 2630 | 0.170 |
Why?
|
| Wnt Proteins | 2 | 2015 | 722 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 6 | 2020 | 5337 | 0.160 |
Why?
|
| Hep G2 Cells | 3 | 2017 | 379 | 0.160 |
Why?
|
| Transferrin | 1 | 2020 | 283 | 0.160 |
Why?
|
| Plasmodium falciparum | 2 | 2023 | 1738 | 0.160 |
Why?
|
| Neoplasm Transplantation | 4 | 2020 | 2014 | 0.160 |
Why?
|
| Protein Engineering | 1 | 2003 | 550 | 0.160 |
Why?
|
| Cricetulus | 2 | 2011 | 805 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2018 | 2329 | 0.160 |
Why?
|
| Dimethyl Sulfoxide | 3 | 2021 | 251 | 0.160 |
Why?
|
| Microinjections | 5 | 2008 | 320 | 0.160 |
Why?
|
| Blood Cell Count | 3 | 2016 | 405 | 0.160 |
Why?
|
| Erwinia | 1 | 2018 | 22 | 0.160 |
Why?
|
| Hypothermia | 1 | 2020 | 190 | 0.160 |
Why?
|
| Candidiasis, Invasive | 1 | 2019 | 27 | 0.160 |
Why?
|
| Liver Failure, Acute | 3 | 2006 | 183 | 0.160 |
Why?
|
| Zinc | 1 | 2003 | 675 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2024 | 8102 | 0.160 |
Why?
|
| HIV-1 | 2 | 2022 | 6944 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2020 | 618 | 0.160 |
Why?
|
| Lipogenesis | 1 | 2020 | 217 | 0.160 |
Why?
|
| Cytoplasm | 3 | 2020 | 1500 | 0.160 |
Why?
|
| Cycloparaffins | 1 | 2018 | 12 | 0.160 |
Why?
|
| Immediate-Early Proteins | 1 | 2021 | 444 | 0.150 |
Why?
|
| Biosensing Techniques | 1 | 2005 | 642 | 0.150 |
Why?
|
| Gene Expression | 4 | 2014 | 7584 | 0.150 |
Why?
|
| Microscopy, Phase-Contrast | 3 | 2009 | 110 | 0.150 |
Why?
|
| Anopheles | 1 | 2020 | 193 | 0.150 |
Why?
|
| Pseudomonas | 1 | 2018 | 124 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2020 | 2476 | 0.150 |
Why?
|
| Mice, Inbred Strains | 7 | 2012 | 1770 | 0.150 |
Why?
|
| HIV Infections | 4 | 2022 | 17533 | 0.150 |
Why?
|
| Microbiological Techniques | 1 | 2019 | 96 | 0.150 |
Why?
|
| Solutions | 4 | 2009 | 403 | 0.150 |
Why?
|
| Propylene Glycol | 2 | 2008 | 29 | 0.150 |
Why?
|
| Wound Healing | 3 | 2012 | 2792 | 0.150 |
Why?
|
| Candida | 1 | 2019 | 172 | 0.150 |
Why?
|
| Ribosomal Proteins | 1 | 2020 | 366 | 0.140 |
Why?
|
| Bacterial Toxins | 1 | 2003 | 924 | 0.140 |
Why?
|
| Computational Biology | 1 | 2009 | 3559 | 0.140 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2020 | 1758 | 0.140 |
Why?
|
| Skin | 4 | 2010 | 4489 | 0.140 |
Why?
|
| Academic Medical Centers | 1 | 2008 | 2780 | 0.140 |
Why?
|
| Viscoelastic Substances | 2 | 2014 | 21 | 0.140 |
Why?
|
| HEK293 Cells | 2 | 2024 | 4260 | 0.140 |
Why?
|
| Urea | 4 | 2009 | 448 | 0.140 |
Why?
|
| Automation, Laboratory | 1 | 2017 | 102 | 0.140 |
Why?
|
| Mechanical Phenomena | 1 | 2018 | 141 | 0.140 |
Why?
|
| Signal Transduction | 13 | 2021 | 23601 | 0.140 |
Why?
|
| Prolactin | 1 | 2019 | 625 | 0.140 |
Why?
|
| Apoptosis | 4 | 2024 | 9514 | 0.140 |
Why?
|
| Miniaturization | 4 | 2007 | 150 | 0.140 |
Why?
|
| Silicon Dioxide | 1 | 2018 | 217 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2025 | 3655 | 0.130 |
Why?
|
| Androstenes | 1 | 2018 | 178 | 0.130 |
Why?
|
| Mitosis | 1 | 2021 | 1173 | 0.130 |
Why?
|
| beta-Globins | 1 | 2017 | 112 | 0.130 |
Why?
|
| Cytoskeleton | 4 | 2010 | 1178 | 0.130 |
Why?
|
| Lung Neoplasms | 7 | 2018 | 13451 | 0.130 |
Why?
|
| Liver Neoplasms | 3 | 2018 | 4353 | 0.130 |
Why?
|
| Regenerative Medicine | 1 | 2019 | 303 | 0.130 |
Why?
|
| Calorimetry, Differential Scanning | 3 | 2008 | 92 | 0.130 |
Why?
|
| Mice, Inbred NOD | 5 | 2021 | 1837 | 0.130 |
Why?
|
| Microtubules | 3 | 2013 | 1062 | 0.130 |
Why?
|
| Megakaryocytes | 1 | 2020 | 557 | 0.130 |
Why?
|
| Electrolytes | 2 | 2007 | 280 | 0.120 |
Why?
|
| Stress, Physiological | 3 | 2019 | 1402 | 0.120 |
Why?
|
| Tissue Scaffolds | 3 | 2014 | 934 | 0.120 |
Why?
|
| Malaria, Falciparum | 1 | 2023 | 1075 | 0.120 |
Why?
|
| Adsorption | 2 | 2013 | 200 | 0.120 |
Why?
|
| BRCA2 Protein | 1 | 2020 | 800 | 0.120 |
Why?
|
| Anti-HIV Agents | 2 | 2022 | 4559 | 0.120 |
Why?
|
| Cell Communication | 3 | 2013 | 1660 | 0.120 |
Why?
|
| B-Lymphocytes | 3 | 2006 | 4778 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2015 | 66 | 0.120 |
Why?
|
| Disaccharides | 1 | 2015 | 170 | 0.120 |
Why?
|
| Proteomics | 3 | 2022 | 3910 | 0.120 |
Why?
|
| Hypothermia, Induced | 1 | 2020 | 752 | 0.120 |
Why?
|
| von Willebrand Factor | 1 | 2018 | 676 | 0.110 |
Why?
|
| Extracellular Matrix | 2 | 2014 | 1727 | 0.110 |
Why?
|
| Platelet Activation | 1 | 2017 | 645 | 0.110 |
Why?
|
| Bone Marrow Cells | 2 | 2019 | 2412 | 0.110 |
Why?
|
| DNA, Neoplasm | 2 | 2010 | 1742 | 0.110 |
Why?
|
| Physics | 1 | 2014 | 92 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 2 | 2020 | 1352 | 0.110 |
Why?
|
| Phenylthiohydantoin | 1 | 2015 | 206 | 0.110 |
Why?
|
| Materials Testing | 4 | 2015 | 868 | 0.110 |
Why?
|
| Intracellular Space | 1 | 2014 | 198 | 0.110 |
Why?
|
| Microtechnology | 2 | 2011 | 64 | 0.110 |
Why?
|
| Precancerous Conditions | 2 | 2017 | 976 | 0.110 |
Why?
|
| BRCA1 Protein | 1 | 2020 | 1153 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2009 | 8923 | 0.110 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 735 | 0.110 |
Why?
|
| Embryo Transfer | 7 | 2014 | 525 | 0.110 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2017 | 521 | 0.110 |
Why?
|
| Gold | 1 | 2017 | 482 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2021 | 3608 | 0.100 |
Why?
|
| Cell Differentiation | 7 | 2011 | 11641 | 0.100 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2018 | 451 | 0.100 |
Why?
|
| Protein Isoforms | 1 | 2017 | 1718 | 0.100 |
Why?
|
| Extracellular Space | 1 | 2014 | 563 | 0.100 |
Why?
|
| Oxygen Isotopes | 1 | 2012 | 41 | 0.100 |
Why?
|
| Sensitivity and Specificity | 8 | 2013 | 14652 | 0.100 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2012 | 55 | 0.100 |
Why?
|
| Cattle | 5 | 2011 | 3801 | 0.100 |
Why?
|
| Antigens, CD | 4 | 2015 | 4025 | 0.100 |
Why?
|
| Acetylation | 1 | 2015 | 1053 | 0.100 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2016 | 540 | 0.100 |
Why?
|
| Metal Nanoparticles | 1 | 2017 | 403 | 0.100 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2012 | 63 | 0.100 |
Why?
|
| Brain Neoplasms | 3 | 2020 | 9071 | 0.100 |
Why?
|
| Biological Specimen Banks | 1 | 2018 | 786 | 0.100 |
Why?
|
| GPI-Linked Proteins | 3 | 2011 | 472 | 0.100 |
Why?
|
| Carcinoma, Papillary | 1 | 2017 | 788 | 0.100 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2005 | 423 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1084 | 0.100 |
Why?
|
| Cell Shape | 1 | 2013 | 373 | 0.100 |
Why?
|
| Liver Transplantation | 4 | 2020 | 2412 | 0.100 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2011 | 29 | 0.100 |
Why?
|
| Nanotubes, Carbon | 1 | 2012 | 71 | 0.100 |
Why?
|
| Carbohydrate Sequence | 1 | 2012 | 410 | 0.100 |
Why?
|
| Blood Viscosity | 1 | 2012 | 125 | 0.090 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2013 | 135 | 0.090 |
Why?
|
| Cell-Derived Microparticles | 1 | 2013 | 160 | 0.090 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2011 | 157 | 0.090 |
Why?
|
| Killifishes | 1 | 2011 | 9 | 0.090 |
Why?
|
| Microscopy | 2 | 2023 | 901 | 0.090 |
Why?
|
| Embryonic Development | 7 | 2012 | 718 | 0.090 |
Why?
|
| Stochastic Processes | 2 | 2010 | 358 | 0.090 |
Why?
|
| Plant Proteins | 2 | 2011 | 374 | 0.090 |
Why?
|
| Diffusion | 2 | 2021 | 808 | 0.090 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2013 | 1917 | 0.090 |
Why?
|
| DNA | 5 | 2023 | 7202 | 0.090 |
Why?
|
| Caenorhabditis | 1 | 2011 | 39 | 0.090 |
Why?
|
| Raffinose | 2 | 2024 | 57 | 0.090 |
Why?
|
| Glioblastoma | 2 | 2018 | 3459 | 0.090 |
Why?
|
| Ischemia | 1 | 2020 | 1909 | 0.090 |
Why?
|
| Mycobacterium smegmatis | 1 | 2011 | 126 | 0.090 |
Why?
|
| Cell Extracts | 2 | 2011 | 134 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 16047 | 0.090 |
Why?
|
| Hyaluronic Acid | 1 | 2014 | 484 | 0.090 |
Why?
|
| Melanoma | 2 | 2020 | 5719 | 0.090 |
Why?
|
| Live Birth | 1 | 2014 | 516 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4562 | 0.090 |
Why?
|
| T-Lymphocytes | 2 | 2006 | 10261 | 0.090 |
Why?
|
| Biological Transport, Active | 2 | 2012 | 323 | 0.090 |
Why?
|
| Cell Migration Inhibition | 2 | 2008 | 97 | 0.080 |
Why?
|
| Mass Spectrometry | 2 | 2019 | 2194 | 0.080 |
Why?
|
| Molecular Structure | 2 | 2012 | 1885 | 0.080 |
Why?
|
| Osmolar Concentration | 3 | 2005 | 655 | 0.080 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2012 | 409 | 0.080 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2010 | 85 | 0.080 |
Why?
|
| Liver Diseases | 1 | 2018 | 1303 | 0.080 |
Why?
|
| Ribonucleotides | 1 | 2010 | 114 | 0.080 |
Why?
|
| Cytoprotection | 2 | 2017 | 200 | 0.080 |
Why?
|
| HL-60 Cells | 2 | 2008 | 364 | 0.080 |
Why?
|
| Nylons | 1 | 2009 | 47 | 0.080 |
Why?
|
| Formamides | 1 | 2009 | 22 | 0.080 |
Why?
|
| Nocodazole | 1 | 2009 | 95 | 0.080 |
Why?
|
| Lasers, Solid-State | 1 | 2012 | 183 | 0.080 |
Why?
|
| Histones | 1 | 2020 | 2584 | 0.080 |
Why?
|
| Organ Transplantation | 1 | 2019 | 1174 | 0.080 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2011 | 755 | 0.080 |
Why?
|
| Cell Migration Assays | 1 | 2008 | 22 | 0.080 |
Why?
|
| Soybean Oil | 1 | 2010 | 139 | 0.080 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 698 | 0.080 |
Why?
|
| Cluster Analysis | 3 | 2015 | 2721 | 0.080 |
Why?
|
| Molecular Sequence Data | 5 | 2013 | 17594 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2023 | 4424 | 0.080 |
Why?
|
| Skin Transplantation | 2 | 2006 | 1098 | 0.080 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2013 | 488 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2015 | 1857 | 0.080 |
Why?
|
| Bandages | 1 | 2010 | 269 | 0.080 |
Why?
|
| Equipment Failure Analysis | 2 | 2008 | 834 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2018 | 5379 | 0.080 |
Why?
|
| Genomics | 2 | 2018 | 5929 | 0.080 |
Why?
|
| Thermal Conductivity | 1 | 2008 | 15 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2015 | 5389 | 0.080 |
Why?
|
| Serum | 1 | 2009 | 206 | 0.080 |
Why?
|
| Ascitic Fluid | 1 | 2008 | 190 | 0.080 |
Why?
|
| Plasma | 2 | 2021 | 579 | 0.080 |
Why?
|
| Exudates and Transudates | 1 | 2008 | 173 | 0.080 |
Why?
|
| Biophysical Phenomena | 1 | 2009 | 318 | 0.070 |
Why?
|
| Hot Temperature | 3 | 2010 | 1433 | 0.070 |
Why?
|
| Ethylene Glycol | 1 | 2008 | 31 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 2 | 2011 | 1612 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2017 | 12768 | 0.070 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2006 | 297 | 0.070 |
Why?
|
| Bone Neoplasms | 2 | 2018 | 2567 | 0.070 |
Why?
|
| Iron Chelating Agents | 1 | 2009 | 142 | 0.070 |
Why?
|
| Ectoderm | 1 | 2008 | 138 | 0.070 |
Why?
|
| Melanoma, Experimental | 2 | 2014 | 558 | 0.070 |
Why?
|
| Biological Transport | 2 | 2018 | 2081 | 0.070 |
Why?
|
| Mitochondria | 2 | 2013 | 3673 | 0.070 |
Why?
|
| Acute Lung Injury | 1 | 2011 | 377 | 0.070 |
Why?
|
| Fermentation | 1 | 2008 | 141 | 0.070 |
Why?
|
| Cadherins | 3 | 2022 | 900 | 0.070 |
Why?
|
| Prostate | 2 | 2015 | 1755 | 0.070 |
Why?
|
| Genes, erbB-1 | 1 | 2008 | 161 | 0.070 |
Why?
|
| Plastics | 1 | 2008 | 117 | 0.070 |
Why?
|
| Hemorheology | 1 | 2007 | 144 | 0.070 |
Why?
|
| Chemotaxis | 2 | 2012 | 596 | 0.070 |
Why?
|
| Mitochondrial Proteins | 2 | 2013 | 975 | 0.070 |
Why?
|
| Genotype | 5 | 2021 | 13024 | 0.070 |
Why?
|
| Connexin 43 | 1 | 2008 | 202 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2009 | 4348 | 0.070 |
Why?
|
| Case-Control Studies | 4 | 2018 | 22223 | 0.070 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2008 | 220 | 0.070 |
Why?
|
| Lymphocyte Subsets | 2 | 2005 | 315 | 0.070 |
Why?
|
| Germ Layers | 1 | 2007 | 72 | 0.070 |
Why?
|
| Viscosity | 1 | 2007 | 334 | 0.070 |
Why?
|
| Disease Models, Animal | 7 | 2023 | 18293 | 0.070 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2007 | 48 | 0.070 |
Why?
|
| Albumins | 3 | 2005 | 577 | 0.070 |
Why?
|
| Cell Nucleus | 2 | 2012 | 2867 | 0.070 |
Why?
|
| Organelles | 1 | 2009 | 264 | 0.070 |
Why?
|
| Survival Rate | 3 | 2014 | 12795 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 269 | 0.070 |
Why?
|
| Adenine | 2 | 2020 | 994 | 0.070 |
Why?
|
| Blood Chemical Analysis | 1 | 2008 | 433 | 0.070 |
Why?
|
| Hemoperfusion | 1 | 2006 | 13 | 0.070 |
Why?
|
| Androgen Antagonists | 1 | 2015 | 1411 | 0.070 |
Why?
|
| Gap Junctions | 1 | 2008 | 229 | 0.070 |
Why?
|
| Molecular Probe Techniques | 1 | 2007 | 111 | 0.070 |
Why?
|
| Cell Lineage | 3 | 2017 | 2573 | 0.070 |
Why?
|
| Antioxidants | 2 | 2017 | 1670 | 0.060 |
Why?
|
| Fluorescent Dyes | 2 | 2012 | 1930 | 0.060 |
Why?
|
| Transfection | 2 | 2011 | 5743 | 0.060 |
Why?
|
| Myocardium | 2 | 2011 | 4760 | 0.060 |
Why?
|
| Body Weight | 4 | 2007 | 4622 | 0.060 |
Why?
|
| Solubility | 1 | 2007 | 1078 | 0.060 |
Why?
|
| Rotation | 1 | 2007 | 513 | 0.060 |
Why?
|
| Sepsis | 1 | 2020 | 2606 | 0.060 |
Why?
|
| Membrane Potentials | 1 | 2009 | 1083 | 0.060 |
Why?
|
| Receptor, erbB-2 | 1 | 2016 | 2593 | 0.060 |
Why?
|
| Chromatography, Affinity | 1 | 2006 | 521 | 0.060 |
Why?
|
| Skin, Artificial | 1 | 2006 | 89 | 0.060 |
Why?
|
| Swine | 3 | 2024 | 5988 | 0.060 |
Why?
|
| Mutation | 9 | 2021 | 30198 | 0.060 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2005 | 86 | 0.060 |
Why?
|
| Embryonic and Fetal Development | 2 | 2003 | 419 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2009 | 791 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2022 | 5696 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2006 | 313 | 0.060 |
Why?
|
| Spectrum Analysis | 1 | 2007 | 443 | 0.060 |
Why?
|
| Avidin | 1 | 2004 | 44 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2008 | 854 | 0.060 |
Why?
|
| Containment of Biohazards | 1 | 2024 | 39 | 0.060 |
Why?
|
| Cell Hypoxia | 2 | 2020 | 647 | 0.060 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2008 | 565 | 0.060 |
Why?
|
| Pentanoic Acids | 1 | 2024 | 19 | 0.060 |
Why?
|
| Enterotoxins | 1 | 2006 | 366 | 0.060 |
Why?
|
| Organizational Innovation | 1 | 2008 | 541 | 0.060 |
Why?
|
| Muscle, Skeletal | 3 | 2006 | 4958 | 0.060 |
Why?
|
| Liposomes | 1 | 2008 | 788 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2010 | 995 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2006 | 416 | 0.060 |
Why?
|
| Granulocytes | 1 | 2006 | 549 | 0.060 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2005 | 169 | 0.060 |
Why?
|
| Microscopy, Atomic Force | 1 | 2004 | 250 | 0.060 |
Why?
|
| Estrogen Receptor alpha | 2 | 2021 | 578 | 0.060 |
Why?
|
| Serum Albumin, Bovine | 1 | 2024 | 318 | 0.060 |
Why?
|
| Swine, Miniature | 1 | 2006 | 971 | 0.060 |
Why?
|
| Basement Membrane | 1 | 2005 | 349 | 0.050 |
Why?
|
| Fertilization in Vitro | 6 | 2009 | 1306 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2007 | 1524 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 11022 | 0.050 |
Why?
|
| RNA, Small Interfering | 3 | 2020 | 3421 | 0.050 |
Why?
|
| Oocysts | 1 | 2023 | 16 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2011 | 2927 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 1599 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 9 | 2014 | 22332 | 0.050 |
Why?
|
| Collagen | 3 | 2014 | 2618 | 0.050 |
Why?
|
| Glucose | 5 | 2016 | 4335 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2014 | 2674 | 0.050 |
Why?
|
| Base Sequence | 2 | 2013 | 12403 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2009 | 790 | 0.050 |
Why?
|
| Escherichia coli | 2 | 2012 | 4214 | 0.050 |
Why?
|
| Elastic Modulus | 2 | 2016 | 208 | 0.050 |
Why?
|
| Neoplastic Processes | 1 | 2022 | 35 | 0.050 |
Why?
|
| Receptors, IgG | 1 | 2006 | 559 | 0.050 |
Why?
|
| Estrogen Antagonists | 1 | 2023 | 150 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2822 | 0.050 |
Why?
|
| Allopurinol | 1 | 2024 | 203 | 0.050 |
Why?
|
| Ruthenium | 1 | 2002 | 19 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 1393 | 0.050 |
Why?
|
| Mice, Inbred ICR | 2 | 2014 | 339 | 0.050 |
Why?
|
| Zygote | 1 | 2003 | 117 | 0.050 |
Why?
|
| Antigens, CD19 | 1 | 2005 | 443 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2010 | 1608 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 3236 | 0.050 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 13648 | 0.050 |
Why?
|
| Drug Monitoring | 1 | 2008 | 962 | 0.050 |
Why?
|
| Insemination, Artificial | 1 | 2002 | 99 | 0.050 |
Why?
|
| Phenotype | 5 | 2016 | 16721 | 0.050 |
Why?
|
| Calibration | 1 | 2004 | 814 | 0.050 |
Why?
|
| Docosahexaenoic Acids | 1 | 2008 | 916 | 0.050 |
Why?
|
| Connexins | 1 | 2004 | 356 | 0.050 |
Why?
|
| Plasmodium | 1 | 2024 | 248 | 0.050 |
Why?
|
| Oxygenators, Membrane | 1 | 2002 | 57 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2009 | 1728 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2022 | 3618 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2007 | 2485 | 0.050 |
Why?
|
| Phenylacetates | 1 | 2021 | 112 | 0.050 |
Why?
|
| Glutathione | 1 | 2024 | 588 | 0.050 |
Why?
|
| Tissue Transplantation | 1 | 2002 | 128 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 3672 | 0.050 |
Why?
|
| Lysine | 1 | 2006 | 991 | 0.050 |
Why?
|
| Carbohydrate Metabolism | 1 | 2002 | 261 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 3607 | 0.050 |
Why?
|
| Animals, Newborn | 3 | 2014 | 2669 | 0.050 |
Why?
|
| Corticosterone | 1 | 2002 | 301 | 0.050 |
Why?
|
| Feasibility Studies | 2 | 2019 | 5302 | 0.050 |
Why?
|
| Oxygen Consumption | 2 | 2007 | 1870 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2006 | 2477 | 0.050 |
Why?
|
| Cornea | 1 | 2009 | 1316 | 0.050 |
Why?
|
| Heart | 2 | 2006 | 4414 | 0.050 |
Why?
|
| Telemetry | 1 | 2002 | 201 | 0.050 |
Why?
|
| Organ Size | 1 | 2006 | 2260 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2008 | 1341 | 0.040 |
Why?
|
| Cytological Techniques | 1 | 2002 | 220 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 3 | 2014 | 2060 | 0.040 |
Why?
|
| Deferoxamine | 2 | 2012 | 154 | 0.040 |
Why?
|
| Government Regulation | 1 | 2024 | 525 | 0.040 |
Why?
|
| HIV | 1 | 2007 | 1585 | 0.040 |
Why?
|
| Pregnancy | 7 | 2014 | 30260 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2008 | 1884 | 0.040 |
Why?
|
| Spleen | 1 | 2006 | 2296 | 0.040 |
Why?
|
| Microscopy, Confocal | 3 | 2012 | 1966 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2005 | 1731 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2011 | 2892 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2006 | 6424 | 0.040 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2019 | 48 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2004 | 1947 | 0.040 |
Why?
|
| Tissue Survival | 1 | 2019 | 121 | 0.040 |
Why?
|
| Adenosine | 1 | 2024 | 806 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 1999 | 0.040 |
Why?
|
| Cartilage, Articular | 1 | 2006 | 1089 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2021 | 515 | 0.040 |
Why?
|
| Alanine | 1 | 2022 | 612 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2022 | 2878 | 0.040 |
Why?
|
| Myocytes, Cardiac | 2 | 2011 | 1668 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 1673 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2020 | 272 | 0.040 |
Why?
|
| Retinoid X Receptors | 1 | 2019 | 91 | 0.040 |
Why?
|
| RNA Stability | 1 | 2021 | 319 | 0.040 |
Why?
|
| Hepatic Stellate Cells | 1 | 2020 | 117 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2020 | 328 | 0.040 |
Why?
|
| Oligosaccharides | 2 | 2016 | 406 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2021 | 576 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2019 | 4137 | 0.040 |
Why?
|
| Kidney | 2 | 2006 | 7066 | 0.040 |
Why?
|
| Photolysis | 1 | 2018 | 94 | 0.040 |
Why?
|
| Vasodilation | 1 | 2003 | 970 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 5849 | 0.040 |
Why?
|
| Polyesters | 2 | 2011 | 372 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2013 | 7599 | 0.040 |
Why?
|
| Stereotaxic Techniques | 1 | 2020 | 551 | 0.040 |
Why?
|
| 5'-Nucleotidase | 1 | 2019 | 160 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2006 | 4015 | 0.040 |
Why?
|
| Heart Valve Prosthesis | 1 | 2006 | 1466 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2019 | 246 | 0.040 |
Why?
|
| Research Personnel | 1 | 2002 | 590 | 0.040 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2018 | 1534 | 0.040 |
Why?
|
| Receptors, Leptin | 1 | 2019 | 355 | 0.040 |
Why?
|
| Phthalazines | 1 | 2020 | 397 | 0.040 |
Why?
|
| Reperfusion Injury | 1 | 2024 | 1042 | 0.040 |
Why?
|
| Robotics | 1 | 2004 | 809 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2021 | 718 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2021 | 549 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 632 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2020 | 4108 | 0.030 |
Why?
|
| Adult | 10 | 2022 | 223044 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2011 | 939 | 0.030 |
Why?
|
| Disease Progression | 4 | 2020 | 13632 | 0.030 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2019 | 318 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2002 | 1158 | 0.030 |
Why?
|
| Fertilization | 2 | 2009 | 197 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2023 | 1297 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 594 | 0.030 |
Why?
|
| Hardness | 1 | 2016 | 33 | 0.030 |
Why?
|
| Egtazic Acid | 2 | 2007 | 165 | 0.030 |
Why?
|
| Abdominal Neoplasms | 1 | 2018 | 284 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2006 | 2554 | 0.030 |
Why?
|
| U937 Cells | 2 | 2006 | 259 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2019 | 591 | 0.030 |
Why?
|
| Epitopes | 1 | 2022 | 2523 | 0.030 |
Why?
|
| Optics and Photonics | 2 | 2008 | 305 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2019 | 346 | 0.030 |
Why?
|
| Macrophages | 2 | 2013 | 5772 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2003 | 1375 | 0.030 |
Why?
|
| Homeodomain Proteins | 2 | 2018 | 2428 | 0.030 |
Why?
|
| Middle Aged | 11 | 2020 | 223009 | 0.030 |
Why?
|
| Liver Function Tests | 2 | 2007 | 525 | 0.030 |
Why?
|
| Interleukin-1beta | 2 | 2014 | 1028 | 0.030 |
Why?
|
| Critical Illness | 1 | 2008 | 2744 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 2242 | 0.030 |
Why?
|
| Malaria | 1 | 2024 | 1246 | 0.030 |
Why?
|
| Biopsy | 2 | 2018 | 6763 | 0.030 |
Why?
|
| Osteonectin | 1 | 2014 | 33 | 0.030 |
Why?
|
| gamma Catenin | 1 | 2014 | 45 | 0.030 |
Why?
|
| Polyamines | 1 | 2015 | 130 | 0.030 |
Why?
|
| Retinal Dehydrogenase | 1 | 2014 | 78 | 0.030 |
Why?
|
| Electric Impedance | 2 | 2011 | 794 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2002 | 1792 | 0.030 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 3946 | 0.030 |
Why?
|
| Ligands | 2 | 2017 | 3273 | 0.030 |
Why?
|
| Triglycerides | 1 | 2002 | 2441 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 6364 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2010 | 1526 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2002 | 3160 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 2 | 2012 | 3602 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 506 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2002 | 2394 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2020 | 1166 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1789 | 0.030 |
Why?
|
| Brain | 1 | 2020 | 27171 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 6493 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 10729 | 0.030 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 517 | 0.030 |
Why?
|
| Indoles | 1 | 2021 | 1839 | 0.030 |
Why?
|
| Software | 2 | 2010 | 4462 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 6499 | 0.030 |
Why?
|
| Mice, Knockout | 3 | 2019 | 14448 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 7478 | 0.030 |
Why?
|
| Amino Acids, Dicarboxylic | 1 | 2012 | 22 | 0.030 |
Why?
|
| Gelatin | 1 | 2015 | 227 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 2056 | 0.030 |
Why?
|
| Binding Sites | 1 | 2021 | 6001 | 0.030 |
Why?
|
| Wnt2 Protein | 1 | 2012 | 29 | 0.030 |
Why?
|
| Contact Inhibition | 1 | 2012 | 46 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1107 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 629 | 0.030 |
Why?
|
| Dynamins | 1 | 2013 | 138 | 0.030 |
Why?
|
| Cobalt | 1 | 2012 | 145 | 0.030 |
Why?
|
| Hepatitis B, Chronic | 1 | 2017 | 412 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2024 | 54802 | 0.020 |
Why?
|
| Thienamycins | 1 | 2011 | 29 | 0.020 |
Why?
|
| Adenoviridae | 2 | 2006 | 1092 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2012 | 5020 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 498 | 0.020 |
Why?
|
| Genome, Human | 1 | 2005 | 4448 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 528 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2012 | 381 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 720 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2004 | 3401 | 0.020 |
Why?
|
| MADS Domain Proteins | 1 | 2011 | 19 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2011 | 297 | 0.020 |
Why?
|
| Morpholines | 1 | 2014 | 577 | 0.020 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2013 | 280 | 0.020 |
Why?
|
| Decanoates | 1 | 2011 | 55 | 0.020 |
Why?
|
| Metabolomics | 1 | 2020 | 1668 | 0.020 |
Why?
|
| Purines | 1 | 2014 | 615 | 0.020 |
Why?
|
| Aged | 7 | 2020 | 171117 | 0.020 |
Why?
|
| Chromatography | 1 | 2011 | 187 | 0.020 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2011 | 99 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 14071 | 0.020 |
Why?
|
| Cycloserine | 1 | 2011 | 118 | 0.020 |
Why?
|
| Droughts | 1 | 2011 | 27 | 0.020 |
Why?
|
| Tissue and Organ Procurement | 1 | 2019 | 989 | 0.020 |
Why?
|
| Host-Parasite Interactions | 1 | 2013 | 302 | 0.020 |
Why?
|
| Weight Loss | 1 | 2002 | 2710 | 0.020 |
Why?
|
| Catalysis | 1 | 2012 | 770 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2012 | 252 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2013 | 6069 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2015 | 903 | 0.020 |
Why?
|
| Oxygen | 1 | 2002 | 4241 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 370 | 0.020 |
Why?
|
| Bacteriological Techniques | 1 | 2011 | 276 | 0.020 |
Why?
|
| Culture | 1 | 2014 | 622 | 0.020 |
Why?
|
| Optical Phenomena | 1 | 2011 | 103 | 0.020 |
Why?
|
| Genes, Mitochondrial | 1 | 2010 | 59 | 0.020 |
Why?
|
| Sorbitol | 1 | 2010 | 61 | 0.020 |
Why?
|
| Nitriles | 1 | 2015 | 982 | 0.020 |
Why?
|
| Biotinylation | 1 | 2010 | 184 | 0.020 |
Why?
|
| Isoniazid | 1 | 2011 | 281 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2019 | 2058 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 904 | 0.020 |
Why?
|
| Microcirculation | 1 | 2014 | 1280 | 0.020 |
Why?
|
| Umbilical Cord | 1 | 2011 | 180 | 0.020 |
Why?
|
| Logistic Models | 2 | 2017 | 13266 | 0.020 |
Why?
|
| Benzamides | 1 | 2015 | 1377 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3819 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2013 | 523 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2019 | 2395 | 0.020 |
Why?
|
| Mesoderm | 1 | 2013 | 679 | 0.020 |
Why?
|
| Osmotic Pressure | 1 | 2010 | 136 | 0.020 |
Why?
|
| Piperazines | 1 | 2020 | 2549 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2015 | 1133 | 0.020 |
Why?
|
| Propylene Glycols | 1 | 2009 | 91 | 0.020 |
Why?
|
| United States | 3 | 2024 | 72903 | 0.020 |
Why?
|
| Rifampin | 1 | 2011 | 351 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2014 | 963 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 2010 | 285 | 0.020 |
Why?
|
| Physical Phenomena | 1 | 2009 | 48 | 0.020 |
Why?
|
| Cell-Free System | 1 | 2009 | 339 | 0.020 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2008 | 49 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 2844 | 0.020 |
Why?
|
| Quinazolines | 1 | 2015 | 1364 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2009 | 199 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2009 | 251 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2140 | 0.020 |
Why?
|
| Protein Stability | 1 | 2011 | 577 | 0.020 |
Why?
|
| Biomimetic Materials | 1 | 2010 | 170 | 0.020 |
Why?
|
| Electricity | 1 | 2009 | 174 | 0.020 |
Why?
|
| Cell Wall | 1 | 2011 | 420 | 0.020 |
Why?
|
| Catalase | 1 | 2009 | 216 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2010 | 651 | 0.020 |
Why?
|
| T-Box Domain Proteins | 1 | 2011 | 469 | 0.020 |
Why?
|
| Gases | 1 | 2009 | 206 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2009 | 522 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2020 | 2192 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 1119 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2012 | 1978 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2011 | 13400 | 0.020 |
Why?
|
| Systems Biology | 1 | 2012 | 481 | 0.020 |
Why?
|
| Homeostasis | 1 | 2019 | 3336 | 0.020 |
Why?
|
| Markov Chains | 1 | 2012 | 968 | 0.020 |
Why?
|
| Prognosis | 3 | 2017 | 29922 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 1167 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 1066 | 0.020 |
Why?
|
| Litter Size | 1 | 2007 | 49 | 0.020 |
Why?
|
| Breeding | 1 | 2007 | 49 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2009 | 332 | 0.020 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2008 | 122 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2013 | 1477 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 59489 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2011 | 615 | 0.020 |
Why?
|
| Pseudopregnancy | 1 | 2007 | 10 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2013 | 797 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2008 | 623 | 0.020 |
Why?
|
| High Mobility Group Proteins | 1 | 2008 | 180 | 0.020 |
Why?
|
| Aging | 1 | 2006 | 8731 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 752 | 0.020 |
Why?
|
| Sex Ratio | 1 | 2007 | 107 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2014 | 3624 | 0.020 |
Why?
|
| Monitoring, Immunologic | 1 | 2007 | 99 | 0.020 |
Why?
|
| Galactosamine | 1 | 2006 | 26 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 684 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2009 | 576 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2012 | 698 | 0.020 |
Why?
|
| Research Design | 1 | 2002 | 6209 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 6220 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2012 | 933 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2011 | 1617 | 0.020 |
Why?
|
| Peritonitis | 1 | 2008 | 369 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2008 | 282 | 0.020 |
Why?
|
| E-Selectin | 1 | 2008 | 576 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2012 | 5089 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 1959 | 0.020 |
Why?
|
| Extracorporeal Circulation | 1 | 2006 | 182 | 0.020 |
Why?
|
| P-Selectin | 1 | 2008 | 597 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 2007 | 403 | 0.020 |
Why?
|
| Mercury | 1 | 2008 | 291 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2012 | 1458 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 2832 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2006 | 355 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 2012 | 978 | 0.020 |
Why?
|
| Biomimetics | 1 | 2006 | 168 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2006 | 858 | 0.020 |
Why?
|
| Time | 1 | 2007 | 550 | 0.020 |
Why?
|
| Pregnancy Outcome | 2 | 2007 | 2966 | 0.020 |
Why?
|
| Wounds and Injuries | 2 | 2010 | 2511 | 0.020 |
Why?
|
| Starfish | 1 | 2004 | 13 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 1971 | 0.020 |
Why?
|
| Response Elements | 1 | 2006 | 307 | 0.010 |
Why?
|
| Electrochemistry | 1 | 2005 | 142 | 0.010 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 165 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2005 | 456 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 2006 | 415 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 1995 | 0.010 |
Why?
|
| Fibronectins | 1 | 2008 | 719 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2009 | 1072 | 0.010 |
Why?
|
| Transcription Factors | 3 | 2011 | 12131 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2009 | 2171 | 0.010 |
Why?
|
| Fluorescence | 1 | 2007 | 753 | 0.010 |
Why?
|
| Cell Division | 1 | 2011 | 4475 | 0.010 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2014 | 2054 | 0.010 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2004 | 103 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2004 | 515 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2006 | 674 | 0.010 |
Why?
|
| Aorta | 1 | 2012 | 2028 | 0.010 |
Why?
|
| Chemokine CXCL12 | 1 | 2006 | 455 | 0.010 |
Why?
|
| ROC Curve | 1 | 2012 | 3620 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 2006 | 607 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2009 | 1137 | 0.010 |
Why?
|
| Receptors, CCR5 | 1 | 2006 | 491 | 0.010 |
Why?
|
| HEPES | 1 | 2003 | 10 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2011 | 2920 | 0.010 |
Why?
|
| Tromethamine | 1 | 2003 | 30 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2018 | 9347 | 0.010 |
Why?
|
| Computer-Aided Design | 1 | 2005 | 291 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4772 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2006 | 898 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2010 | 1751 | 0.010 |
Why?
|
| Noble Gases | 1 | 2002 | 18 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2005 | 393 | 0.010 |
Why?
|
| Convection | 1 | 2002 | 30 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 4520 | 0.010 |
Why?
|
| Proteome | 1 | 2013 | 1899 | 0.010 |
Why?
|
| Inflammation | 1 | 2003 | 10850 | 0.010 |
Why?
|
| Buffers | 1 | 2002 | 141 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 9373 | 0.010 |
Why?
|
| Meiosis | 1 | 2004 | 326 | 0.010 |
Why?
|
| Body Temperature Regulation | 1 | 1984 | 292 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 2011 | 9601 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 201 | 0.010 |
Why?
|
| Fertility | 1 | 2007 | 768 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11868 | 0.010 |
Why?
|
| Edetic Acid | 1 | 2002 | 274 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2006 | 825 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2006 | 1347 | 0.010 |
Why?
|
| Pregnancy Rate | 1 | 2005 | 655 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2008 | 2601 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 2010 | 9249 | 0.010 |
Why?
|
| Ovum | 1 | 2002 | 187 | 0.010 |
Why?
|
| Principal Component Analysis | 1 | 2005 | 951 | 0.010 |
Why?
|
| Linear Models | 1 | 2012 | 5876 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6203 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2012 | 8278 | 0.010 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2008 | 807 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2014 | 4913 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1984 | 665 | 0.010 |
Why?
|
| Receptors, CXCR4 | 1 | 2006 | 728 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5753 | 0.010 |
Why?
|
| Embryo Implantation | 1 | 2002 | 271 | 0.010 |
Why?
|
| Lipids | 1 | 2012 | 3315 | 0.010 |
Why?
|
| Chromatin | 1 | 2012 | 2980 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 2010 | 2464 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15398 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 3737 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 2007 | 1337 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 2686 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2004 | 1134 | 0.010 |
Why?
|
| Electrodes | 1 | 2002 | 609 | 0.010 |
Why?
|
| Forecasting | 1 | 2009 | 2936 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 2002 | 879 | 0.010 |
Why?
|
| Physical Fitness | 1 | 1984 | 742 | 0.010 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2008 | 1396 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 4034 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2006 | 1801 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2268 | 0.010 |
Why?
|
| Fluid Therapy | 1 | 2002 | 584 | 0.010 |
Why?
|
| Cancer Vaccines | 1 | 2006 | 1044 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 2207 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 2004 | 1273 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2006 | 2570 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2006 | 3222 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2005 | 2143 | 0.010 |
Why?
|
| International Cooperation | 1 | 2002 | 1432 | 0.010 |
Why?
|
| Amino Acids | 1 | 2002 | 1709 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2012 | 3424 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 3529 | 0.010 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2006 | 1510 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 39193 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2018 | 65188 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2002 | 1509 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2009 | 8733 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 8529 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20659 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2002 | 1806 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 11206 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 14751 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 12509 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 9550 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 18380 | 0.010 |
Why?
|
| Patient Selection | 1 | 2005 | 4255 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2002 | 5501 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 81514 | 0.010 |
Why?
|
| Internet | 1 | 2002 | 3106 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 26318 | 0.000 |
Why?
|
| Hospitalization | 1 | 2008 | 10808 | 0.000 |
Why?
|
| Infant | 1 | 2010 | 36386 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2010 | 42500 | 0.000 |
Why?
|
| Databases, Factual | 1 | 2002 | 8067 | 0.000 |
Why?
|
| Aerobiosis | 1 | 1984 | 99 | 0.000 |
Why?
|
| Acclimatization | 1 | 1984 | 113 | 0.000 |
Why?
|
| Young Adult | 1 | 2010 | 59889 | 0.000 |
Why?
|
| Sweating | 1 | 1984 | 155 | 0.000 |
Why?
|
| Child | 1 | 2010 | 80564 | 0.000 |
Why?
|
| Heart Rate | 1 | 1984 | 4204 | 0.000 |
Why?
|